Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor.

Abstract

BACKGROUND The ability to provide safe and effective pharmacotherapy during obstetric complications, such as preterm labor or postpartum hemorrhage, is hampered by the systemic toxicity of therapeutic agents leading to adverse side effects in the mother and fetus. Development of novel strategies to target tocolytic and uterotonic agents specifically to… (More)
DOI: 10.1016/j.ajog.2016.08.027

Topics

Cite this paper

@article{Paul2017DrugDT, title={Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor.}, author={Jonathan W. Paul and Susan Hua and Marina Ilicic and J. M. Estaran Tolosa and Trent Butler and Sarah Robertson and Roger Smith}, journal={American journal of obstetrics and gynecology}, year={2017}, volume={216 3}, pages={283.e1-283.e14} }